Sign In
Buy ARGX
$844.50
+13.71 (+1.65%)
At Close: Aug 04, 2026
argenx to Participate in Upcoming Virtual Investor Conferences
01:00am, Monday, 09'th Nov 2020
November 9, 2020 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune d
argenx to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
05:00am, Tuesday, 04'th Aug 2020
August 4, 2020 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune
argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q2 2020 Results - Earnings Call Transcript
11:59am, Sunday, 02'nd Aug 2020
argenx SE (NASDAQ:ARGX) Q2 2020 Earnings Conference Call July 30, 2020 8:30 AM ET Company Participants Beth DelGiacco - Vice President, Investor Relations Tim Van Hauwermeiren - Chief Executive Office
argenx SE 2020 Q2 - Results - Earnings Call Presentation
03:58pm, Saturday, 01'st Aug 2020
The following slide deck was published by argenx SE in conjunction with their 2020 Q2 earnings call.
argenx reports half year 2020 financial results and provides second quarter business update
05:00am, Thursday, 30'th Jul 2020
* Biologics License Application for efgartigimod in generalized myasthenia gravis on track to be submitted to U.S. Food and Drug Administration by end of year * Full data from ADAPT trial to be pr
Earnings Preview: argenx
05:46pm, Wednesday, 29'th Jul 2020
On Thursday, July 30, argenx (NASDAQ: ARGX) will release its latest earnings report. Benzinga's outlook for argenx is included in the following report.Earnings and Revenue argenx EPS will likely be ne
Did Hedge Funds Make The Right Call On argenx SE (ARGX) ?
04:15pm, Monday, 20'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
argenx (ARGX): Strong Industry, Solid Earnings Estimate Revisions
01:24pm, Wednesday, 01'st Jul 2020
argenx (ARGX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Is argenx SE (ARGX) A Good Stock To Buy?
03:09pm, Monday, 15'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
argenx announces closing of global offering
08:00pm, Monday, 01'st Jun 2020
Breda, the Netherlands / Ghent, Belgium — argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the trea
argenx announces full exercise of underwriters’ option to purchase additional ADSs
05:00am, Friday, 29'th May 2020
Breda, the Netherlands / Ghent, Belgium — argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the trea
argenx raises $750 million in gross proceeds in a global offering
04:15am, Thursday, 28'th May 2020
Breda, the Netherlands / Ghent, Belgium — argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the trea
argenx Up on Positive Data from Pivotal Efgartigimod Study
02:08pm, Wednesday, 27'th May 2020
argenx's (ARGX) lead pipeline candidate, efgartigimod, meets primary endpoint in a pivotal study evaluating it in myasthenia gravis. A BLA is likely to be filed by the end of 2020.
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
11:25am, Wednesday, 27'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
argenx announces launch of proposed global offering
08:01pm, Tuesday, 26'th May 2020
Breda, the Netherlands / Ghent, Belgium — argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the trea
